imipenem - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PRIMAXIN imipenem 500mg and cilastatin 500mg (as sodium) powder for injection vial AUST R: 10509Active ingredients:
cilastatin
imipenem
Dosage form:
Injection, powder for
Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd
Phone:
1800818553
|
Deletion from market:
29 Feb 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An imipenem/cilastatin injection product may be available via the Special Access Scheme (SAS): https://www.tga.gov.au/products/prescribe-unapproved-therapeutic-good-health-practitioners
|